azd2563 has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balasubramanian, V; Bharath, S; Butler, SL; Deshpande, A; Gaonkar, S; Kumar, N; Mahesh, KN; Melnick, D; Reddy, J; Shandil, R; Solapure, S; Wright, L | 1 |
| Betoudji, F; Converse, PJ; Dartois, V; Li, SY; Mdluli, KE; Mendel, CM; Nuermberger, EL; Tasneen, R; Tyagi, S; Williams, K; Yang, T | 1 |
| Johnson, AP | 1 |
1 review(s) available for azd2563 and Disease Models, Animal
| Article | Year |
|---|---|
AZD-2563 AstraZeneca.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Structure-Activity Relationship | 2002 |
2 other study(ies) available for azd2563 and Disease Models, Animal
| Article | Year |
|---|---|
Pharmacokinetic and pharmacodynamic evaluation of AZD5847 in a mouse model of tuberculosis.
Topics: Animals; Area Under Curve; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Resistance, Multiple, Bacterial; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Pulmonary | 2014 |
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
Topics: Animals; Antitubercular Agents; Bacterial Load; Diarylquinolines; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Linezolid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Organophosphates; Oxazoles; Oxazolidinones; Pyrazinamide; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |